Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Clinical trial NCT02528019 · UNKNOWN

Trial details

NCT number: NCT02528019
Sponsor: Kurume University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications

Start date: 2015-08-01
Primary completion: 2017-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.